Claroty
Last updated: May 10, 2026
Cyber-physical systems security platform for industrial, healthcare, commercial, and public-sector environments, combining asset visibility, exposure management, network protection, secure access, and OT threat detection.
Visit WebsiteCompany Overview
Claroty protects cyber-physical systems: the connected industrial, healthcare, building, utility, transportation, and public-sector assets that sit between traditional IT and the physical world. Its platform covers asset inventory, exposure management, network protection, secure access, threat detection, and operational efficiency across both cloud and on-prem deployments. The useful diligence lens is not generic cybersecurity; it is whether Claroty can keep becoming the system of record for fragile operational environments where downtime and safety consequences matter.
The technical problem is durable. CPS environments contain long-lived equipment, proprietary protocols, vendor-managed assets, medical devices, building systems, and infrastructure controls that cannot be treated like ordinary laptops or cloud workloads. Claroty's value proposition is to discover those assets safely, understand their context, prioritize exposures, and give operators a path to segmentation, access control, and remediation without disrupting operations. That is why protocol coverage, passive discovery, safe querying, and integrations with SIEM, SOAR, EDR, NAC, and firewall tools matter more than feature slogans.
The company is now a scaled private platform rather than a formative startup. Claroty announced a $150 million Series F round in January 2026, said it works with 24 of the Fortune 100, and stated that the platform is deployed by hundreds of organizations at thousands of sites globally. Its 2025 ten-year milestone release also cited more than 700 employees in 27 countries and more than $100 million in ARR in 2023. Those signals make the record more useful as a category benchmark, strategic partner, or late-stage M&A reference than as an early-stage venture prospect.
The dual-use and alliance relevance are direct. Claroty explicitly serves public-sector use cases, including federal, defense, energy, water, transportation, public safety, and healthcare environments. The same controls that protect manufacturing lines, hospitals, ports, and commercial buildings can harden military facilities, defense suppliers, and critical infrastructure operators. The main diligence questions are valuation, deployment friction, platform consolidation pressure, and whether Claroty can keep its CPS-specific depth as large security vendors push deeper into OT and infrastructure security.
Dual-Use Assessment
Claroty’s core CPS security stack has substantial commercial and defense-adjacent applicability because the same visibility, exposure management, secure access, and threat detection functions used in factories, hospitals, and commercial buildings also apply to utilities, ports, transit, and public-sector critical infrastructure.
Strategic Fit Assessment
Claroty is strategically relevant but no longer a startup-style entry point: it is a scaled private CPS security platform with late-stage financing, global enterprise traction, and mature category positioning. It is most useful as a strategic partner, acquisition benchmark, or late-stage secondary diligence target rather than as a fresh early-stage venture opportunity.
Strategic Value to U.S.-Israel Alliance
Claroty is strategically important because it sits at the intersection of OT security, healthcare security, and critical-infrastructure protection. Its platform maps directly to the kinds of resilience, remote-access control, and exposure-management problems that matter in defense-adjacent and public-sector environments. That makes it relevant for strategic diligence around supply-chain resilience, infrastructure hardening, and cyber-physical risk governance.
Key Technologies
- Passive and active asset discovery
- CPS/XIoT asset profiling
- Exposure management and prioritization
- Threat detection for OT/CPS environments
- Secure remote access for third parties
- Network segmentation and policy recommendation
- SIEM/SOAR/EDR integrations
Use Cases & Applications
- Industrial plant asset inventory and monitoring
- Medical device and hospital CPS security
- Building management system protection
- Utility and critical infrastructure segmentation
- Third-party vendor secure remote access
- Vulnerability and exposure prioritization
- Public-sector OT security and compliance
- SOC integration for OT threat detection
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- Official website Primary public reference for company identity, positioning, and current web presence.
- Profile update timestamp Last updated in the Claw & Talon database on May 10, 2026.
Investor Lens
What this entry is
Private startup
Why it may matter
Claroty may matter as a Cybersecurity entry with not currently an investable standalone company for Israeli technology research.
How an independent investor should read this
Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.
Evidence to verify
- Verify current status
- Verify traction
- Verify cap table/funding
- Verify technical claims
- Verify regulatory/export-control issues
- Verify customer concentration
Main investor questions
- Is the company currently active, independently financeable, and raising or not raising on terms you can verify?
- What customer, revenue, product, and technical evidence supports the company story?
- What valuation, cap table, rights, and follow-on assumptions would govern any private exposure?
- Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
- What evidence would change the thesis or show that the profile is stale?
What not to infer
- Inclusion does not imply endorsement.
- Inclusion does not imply allocation availability or current fundraising.
- Scores do not indicate investment suitability or expected returns.
- Strategic importance does not automatically imply venture return potential.
Diligence questions
- What evidence verifies Claroty's current customer traction, deployment status, and revenue concentration?
- Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
- Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
- How does the platform integrate into existing SOC, cloud, identity, or compliance workflows without adding operational burden?
- Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?
Related sector
See the Cybersecurity sector page for market context, related subcategories, and other Israeli companies in this part of the database.
Related companies
Need a diligence readout?
Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.